287 related articles for article (PubMed ID: 28971761)
1. MicroRNAs in Neuroblastoma: Biomarkers with Therapeutic Potential.
Galardi A; Colletti M; Businaro P; Quintarelli C; Locatelli F; Di Giannatale A
Curr Med Chem; 2018 Feb; 25(5):584-600. PubMed ID: 28971761
[TBL] [Abstract][Full Text] [Related]
2. GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma.
Gholamin S; Mirzaei H; Razavi SM; Hassanian SM; Saadatpour L; Masoudifar A; ShahidSales S; Avan A
J Cell Physiol; 2018 Feb; 233(2):866-879. PubMed ID: 28145567
[TBL] [Abstract][Full Text] [Related]
3. Next generation sequencing of microRNAs from isogenic neuroblastoma cell lines isolated before and after treatment.
Roth SA; Knutsen E; Fiskaa T; Utnes P; Bhavsar S; Hald ØH; Løkke C; Mestdagh P; Johansen SD; Flægstad T; Einvik C
Cancer Lett; 2016 Mar; 372(1):128-36. PubMed ID: 26708804
[TBL] [Abstract][Full Text] [Related]
4. Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic disease.
Ramraj SK; Aravindan S; Somasundaram DB; Herman TS; Natarajan M; Aravindan N
Oncotarget; 2016 Apr; 7(14):18605-19. PubMed ID: 26921195
[TBL] [Abstract][Full Text] [Related]
5. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNA: a new candidate for diagnostic biomarker in neuroblastoma.
Mohammadi M; Goodarzi M; Jaafari MR; Mirzaei HR; Mirzaei H
Cancer Gene Ther; 2016 Nov; 23(11):371-372. PubMed ID: 27740613
[TBL] [Abstract][Full Text] [Related]
7. Translating microRNAs into biomarkers: What is new for pediatric cancer?
de Carvalho IN; de Freitas RM; Vargas FR
Med Oncol; 2016 May; 33(5):49. PubMed ID: 27085875
[TBL] [Abstract][Full Text] [Related]
8. Chemoresistance, cancer stem cells, and miRNA influences: the case for neuroblastoma.
Buhagiar A; Ayers D
Anal Cell Pathol (Amst); 2015; 2015():150634. PubMed ID: 26258008
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cyclin-dependent kinase 1-induced cell death in neuroblastoma cells through the microRNA-34a-MYCN-survivin pathway.
Chen Y; Tsai YH; Tseng SH
Surgery; 2013 Jan; 153(1):4-16. PubMed ID: 22703967
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in gastric cancer: Biomarkers and therapeutic targets.
Ghafouri-Fard S; Vafaee R; Shoorei H; Taheri M
Gene; 2020 Oct; 757():144937. PubMed ID: 32640300
[TBL] [Abstract][Full Text] [Related]
11. New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.
Larrea E; Sole C; Manterola L; Goicoechea I; Armesto M; Arestin M; Caffarel MM; Araujo AM; Araiz M; Fernandez-Mercado M; Lawrie CH
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128908
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer.
Bertoli G; Cava C; Castiglioni I
Int J Mol Sci; 2016 Mar; 17(3):421. PubMed ID: 27011184
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in neuroblastoma: small-sized players with a large impact.
Zhi F; Wang R; Wang Q; Xue L; Deng D; Wang S; Yang Y
Neurochem Res; 2014 Apr; 39(4):613-23. PubMed ID: 24477657
[TBL] [Abstract][Full Text] [Related]
14. The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer.
Schwarzenbach H
Expert Rev Mol Diagn; 2015; 15(9):1159-69. PubMed ID: 26202667
[TBL] [Abstract][Full Text] [Related]
15. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
[TBL] [Abstract][Full Text] [Related]
16. Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients.
Gattolliat CH; Le Teuff G; Combaret V; Mussard E; Valteau-Couanet D; Busson P; Bénard J; Douc-Rasy S
Cancer Med; 2014 Aug; 3(4):998-1009. PubMed ID: 24931722
[TBL] [Abstract][Full Text] [Related]
17. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
18. Opportunities and challenges of circulating biomarkers in neuroblastoma.
Trigg RM; Shaw JA; Turner SD
Open Biol; 2019 May; 9(5):190056. PubMed ID: 31088252
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
20. N-myc and noncoding RNAs in neuroblastoma.
Buechner J; Einvik C
Mol Cancer Res; 2012 Oct; 10(10):1243-53. PubMed ID: 22936790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
